-
The State Food and Drug Administration approved the import registration of Monoravir capsules, Merck's new coronavirus treatment drug
Time of Update: 2023-02-03
(Zhongxin Finance) According to the official website of the State Food and Drug Administration, on December 29, in accordance with the relevant provisions of the Drug Administration Law, the State Food and Drug Administration conducted emergency review and approval in accordance with the special approval procedures for drugs, and conditionally approved the import registration of Merck's new coronavirus treatment drug monogravir capsules (trade name: Lizhuorui/LAGEVRIO).
-
The State Food and Drug Administration approved the marketing of 13 symptomatic treatment drugs for new coronavirus infection
Time of Update: 2023-02-03
Annex: List of varieties serial number Name of the drug specification dosage form Marketing Authorization Holder 1 Acetaminophen vitamin C effervescent tablets Each tablet contains 330 mg of paracetamol and 200 mg of vitamin C Tablets Hainan Taosheng Pharmaceutical Science and Technology Research Institute Co.
-
Stop "making miracles"! Use this medicine to help the intestines to be happy
Time of Update: 2023-01-05
[4]Product Information:ENULOSE-lactulose solution，Actavis Pharma，Inc. 3/2016[5]Product Information:CONSTULOSE-lactulose solution，Actavis Pharma，Inc. 1/2017 [6] Product Information: KRISTALOSE-lactulose powder, for solution, Cumberland Pharmaceuticals Inc. 9/2018 ▼▼▼ Click to read the original article You can also download the app*For medical professionals onlyFocus on digestive health Some people solve the matter of "tuba" in three minutes, and some people are still fighting hard in half an hour .
-
The latest ACR guidelines recommend vaccination for people with rheumatology and musculoskeletal diseases
Time of Update: 2023-01-04
Recently, the American College of Rheumatology (ACR) published a summary of new guidelines for vaccinating patients with rheumatology and musculoskeletal disorders (RMD).
-
Betting on the popular target Claudin 18.2, why does Transcenta Group stand out
Time of Update: 2022-10-25
TST001 is a next-generation antibody designed by Transcenta Group using immune tolerance barrier breakthrough technology, which has higher affinity and stronger NK cell-mediated ADCC tumor killing activity, which also means that TST001 may be effective for patients with high, medium and low expression levels of Claudin18.
-
PET polyester bottle top pressure meter - recommended
Time of Update: 2022-10-03
PET polyester bottle top pressure meter - recommended plastic bottle industry output has been growing, in the face of huge market demand, more enterprises into the plastic bottle market, especially bo
-
Rare epilepsy "life-saving drug" domestic chlorbachan was approved for listing
Time of Update: 2022-09-30
"I can't wait to go to the hospital to prescribe medicine!" On September 21, the family of a child with rare epilepsy told reporters that after the shortage of chlor Bachan caused social concern, "every one or two months, there will be good news coming over, and the solemn statement of the relevant state departments will carry out the import work of chlor Bachan and the declaration of domestic pharmaceutical companies.
-
Introduction to an instrument to test the compression performance of automotive headrests
Time of Update: 2022-09-21
Product structure: Headrest and backrest static strength testing machine is mainly composed of several parts, such as seat headrest and seat back static strength test system, seat installation platform base, H-point positioning system and electrical control system.
-
A new, non-addictive painkiller with fewer side effects
Time of Update: 2022-09-07
The research team, led by scientists from the School of Life Sciences at the University of Warwick, analysed a compound called BnOCPA (benzyloxycyclopentadenosine), which was found to be a powerful selective analgesic, in a test model system.
-
Zuranolone Phase III Clinical Success for Major Depression
Time of Update: 2022-05-01
A major problem in the development of antidepressants is the large placebo effect, and the rapid improvement in scores of both groups of patients can be seen from the time curve, which makes it very difficult for the drug to show outstanding efficacy .
-
Nafuraphine Hydrochloride Orally Disintegrating Tablet, a joint product of 3SBio and Toray of Japan, submitted a marketing application
Time of Update: 2022-01-11
today announced the company’s submission of navura hydrochloride to the China National Medical Products Administration (NMPA) The new drug marketing application of Ephene orally disintegrating tablets (R&D code: TRK-820, Japanese brand name "REMITCH ® ") has been accepted, and it is used to improve the pruritus of hemodialysis patients whose curative effect is not satisfactory .
-
Deqi Pharmaceuticals PD-L1/4-1BB double antibody completed the first patient administration for the treatment of non-Hodgkin’s lymphoma
Time of Update: 2022-01-10
December 24, 2021/eMedClub PR News/--Recently, a leading innovative global biopharmaceutical company Deqi Pharmaceuticals announced the company’s bispecific antibody (PD-L1/4-1BB) candidate product ATG-101 was administered to the first patient in the Phase 1 PROBE clinical trial in Australia, mainly for the treatment of metastatic/advanced solid tumors and B-cell non-Hodgkin’s lymphoma (B-NHL) .
-
The first domestic product
Time of Update: 2022-01-01
The results of the study showed that Polivy+R-CHP significantly improved PFS in patients compared with R-CHOP .
Polivy+R-CHP is the first treatment plan to significantly improve the outcome of such patients compared with standard treatment in 20 years .
-
With the continuous upgrading of the traditional Chinese medicine formula granule industry, pharmaceutical companies are facing stricter supervision
Time of Update: 2021-12-07
In addition, since November 1st, the Hebei Provincial Drug Administration, the Provincial Administration of Traditional Chinese Medicine, the Provincial Health Commission, and the Provincial Medical Insurance Bureau jointly issued the "Hebei Province Traditional Chinese Medicine Formula Granule Management Implementation Rules (Trial)" has also been officially implemented .
-
This pharmaceutical company is amazing
Time of Update: 2021-12-06
Recently, Simcere Pharmaceuticals announced that it has reached a project cooperation with Shanghai Institute of Medicine and others on the global development, production and commercialization of the new coronavirus drug candidate SIM0417 series .
